Not yet recruitingPhase 4NCT06756191

Antifungal Drugs in Pulmonary Mucormycosis

Studying Zygomycosis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Bin Cao
Principal Investigator: Bin Cao
China-Japan Friendship Hospital
Intervention: Combination therapy group(drug)
Enrollment: 312 target
Eligibility: 18 years · All sexes
Timeline: 2025 – 2026

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06756191 on ClinicalTrials.gov

Other trials for Zygomycosis

Additional recruiting or active studies for the same condition.

RECRUITINGNCT07339800
Chest CT Scan in Pulmonary Mucormycosis: Prognostic Value
University Hospital, Strasbourg, France
ACTIVE NOT RECRUITINGNCT07191756
Amphotericin B Versus Isavuconazole for Mucormycosis: A Comparative Efficacy and Safety Study
Qiu Ye
RECRUITINGNCT07185503
Liposomal Amphotericin B Plus Posaconazole/Isavuconazole for Mucormycosis in Hematologic Malignancies: Efficacy and Safety
Institute of Hematology & Blood Diseases Hospital, China
ACTIVE NOT RECRUITINGNCT06515743
Rehabilitation With an Obturator in Maxillary Defects
Menoufia University
RECRUITINGNCT05406037
Biomarkers for Invasive Mucormycosis
University Hospital, Lille
RECRUITINGPHASE2NCT05468372
Amphotericin Versus Posaconazole for Pulmonary Mucormycosis
Post Graduate Institute of Medical Education and Research, Chandigarh

See all trials for Zygomycosis →

← Back to all trials